TUMOR MARKERS PROFILE
Tumor Markers are special substances (proteins, antigens, or hormones) found in blood, urine, or body tissues that may be elevated in certain cancers. These tests help in Early detection, Diagnosis, Monitoring treatment response, and Recurrence tracking of cancers.
🔹 Tests Included in Tumor Markers Profile
AFP (Alpha-fetoprotein): Marker for liver cancer (hepatocellular carcinoma) and certain germ cell tumors.
CEA (Carcinoembryonic Antigen): Elevated in colorectal, pancreatic, gastric, lung, and breast cancers.
CA-125 (Cancer Antigen 125): Associated with ovarian cancer and sometimes endometrial or peritoneal cancers.
CA-19-9 (Cancer Antigen 19-9): Mainly used for pancreatic cancer; also elevated in bile duct and gastrointestinal cancers.
CA-15-3 / CA-27-29 (Cancer Antigens): Primarily used for monitoring breast cancer.
β-hCG (Beta Human Chorionic Gonadotropin): Elevated in testicular, ovarian, and some germ cell tumors.
PSA (Prostate Specific Antigen): Screening and monitoring tool for prostate cancer.
Human Epididymis Protein 4 (HE4): Sensitive marker for ovarian cancer, often used along with CA-125.
Cytokeratin-19 Fragment (CYFRA 21-1): Marker for non-small cell lung cancer (NSCLC).
🔹 Why is it Done?
- Early detection of certain cancers
- Differentiating between benign and malignant growths
- Monitoring effectiveness of cancer treatment
- Detecting recurrence or metastasis
- Guiding treatment decisions in oncology
🔹 Sample Required
- Blood sample (venous)
🔹 Important Note
Tumor markers Alone Cannot Confirm Cancer. They must be interpreted along with clinical findings, imaging, and biopsy results.
🔹 Why Choose SRI PATHOX?
- Wide range of tumor marker testing under one roof
- High-precision laboratory methods
- Fast reporting for timely treatment decisions
- Expert pathologist support for accurate interpretation
